The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting

17 Dec 2021 12:29

RNS Number : 0713W
Synthomer PLC
17 December 2021
 

[17] December 2021

Synthomer plc

Results of General Meeting

Synthomer plc ("Synthomer" or the "Company") announces that the resolutions proposed at its General Meeting (the "Meeting") held earlier today, to approve the acquisition of the Adhesive Resins business of Eastman Chemical Company (the "Acquisition") and to raise the borrowing restriction from £1.5 billion to £2 billion, both as set out in full in the Notice of the Meeting included in the Circular dated 30 November 2021, (together, the "Resolutions") were duly passed unconditionally.

 

In compliance with paragraph 9.6.2R of the Listing Rules, the Resolutions passed at the Meeting have been submitted for filing at the National Storage Mechanism and are available for inspection on their website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Details of the proxy voting instructions, lodged prior to the Meeting, are set out below:

 

For + discretion

Against

Votes Withheld

Resolution

Number and

Description

Votes

%

Votes Cast

Votes

%

Votes Cast

Votes

Resolution 1: To approve the

Acquisition

414,230,586

99.98

80,447

0.02

529,279

Resolution 2: To approve the amendment to Article 93 of the Articles of Association to raise the borrowing restriction to £2 billion

413,463,809

99.80

843,613

0.20

532,890

 

An abstention is not a vote in law and is not counted in the calculation of proportion of votes 'For' or 'Against' a resolution.

 

Number of shareholders

-

2,518

Issued share capital at 6 p.m. on 15 December 2021

-

467,336,041 ordinary shares of 10 pence each

Number of votes per share

-

One

Number of proxies lodged

-

423

 

Commenting on today's announcement, Michael Willome, Chief Executive Officer of Synthomer, said:

"Today's vote represents an overwhelming endorsement from our shareholders and demonstrates their confidence in our strategic rationale for this transaction. Having now spent almost 2 months as Synthomer's CEO, I have seen how the combination of Adhesive Technologies, the Omnova acquisition last year and the investment in multiple areas across the business has resulted in a significant step change in profitability and gives us a strong platform for future growth. As we approach the end of a successful 2021, consistent with our last update, I am confident and excited about the Group's prospects both in the year-ahead and beyond."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMTRBTTMTTBBAB
Date   Source Headline
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.